相关实验视频
Updated: May 13, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
可控制的药物释放和同时 SiO2-药物复合纳米颗粒的载体分解
Silu Zhang1, Zhiqin Chu, Chun Yin
1Department of Physics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Journal of the American Chemical Society
|March 19, 2013
概括
SiO2 - 药物纳米粒子提供可控的药物释放和载体分解. 这项创新促进了药物输送,并促进了纳米颗粒碎片的高效脏分泌,显示了临床应用的前景.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- (SiO2) 纳米粒子是生物相容的载体.
- 控制药物释放对于有效的治疗方法至关重要.
- 同时的载体分解和药物释放仍然是一个挑战.
研究的目的:
- 开发具有同时释放药物和载体分解的SiO2-药物复合纳米粒子.
- 研究药物释放和纳米粒子碎片化的机制.
- 评估这种新型药物输送系统的临床转化潜力.
主要方法:
- 制造具有辐射药物度梯度的SiO2-药物复合纳米粒子.
- 由扩散驱动的药物释放动态的表征.
- 通过药物分子逃生启动的纳米粒子分解的观察.
- 分析所产生的载体碎片的大小和清除.
主要成果:
- 实现了同时释放药物和SiO2载体分解.
- 证明可控制的药物释放主要由扩散控制.
- 从纳米粒子的中心开始观察到触发分解.
- 确认碎片成小的,可以通过脏分泌的载体碎片.
结论:
- SiO2-药物纳米粒子使药物同时释放和载体分解.
- 该系统提供可控制的药物输送和高效的清除.
- 这项技术对诊断和治疗应用具有重大潜力,具有临床翻译前景.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

